Search

Abigail Louise Vanhorn

Examiner (ID: 11338)

Most Active Art Unit
1616
Art Unit(s)
1616, 1636, 1609
Total Applications
1393
Issued Applications
581
Pending Applications
145
Abandoned Applications
710

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18364655 [patent_doc_number] => 20230146246 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-11 [patent_title] => Method of Modulating the Number and the Distribution of Tumor-Infiltrating Leukocytes in Tumors [patent_app_type] => utility [patent_app_number] => 17/844037 [patent_app_country] => US [patent_app_date] => 2022-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36366 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17844037 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/844037
Method of Modulating the Number and the Distribution of Tumor-Infiltrating Leukocytes in Tumors Jun 18, 2022 Pending
Array ( [id] => 17911198 [patent_doc_number] => 20220313593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-06 [patent_title] => Topical preparations comprising polyalkoxylated polyols polyester [patent_app_type] => utility [patent_app_number] => 17/838503 [patent_app_country] => US [patent_app_date] => 2022-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6434 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17838503 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/838503
Topical preparations comprising polyalkoxylated polyols polyester Jun 12, 2022 Abandoned
Array ( [id] => 17911197 [patent_doc_number] => 20220313592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-06 [patent_title] => Liquid Thickener Composition Comprising Polyalkoxylated [patent_app_type] => utility [patent_app_number] => 17/838499 [patent_app_country] => US [patent_app_date] => 2022-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8659 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 330 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17838499 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/838499
Liquid Thickener Composition Comprising Polyalkoxylated Jun 12, 2022 Abandoned
Array ( [id] => 18178692 [patent_doc_number] => 20230039421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-09 [patent_title] => RESIDENCE STRUCTURES AND RELATED METHODS [patent_app_type] => utility [patent_app_number] => 17/836972 [patent_app_country] => US [patent_app_date] => 2022-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34517 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17836972 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/836972
RESIDENCE STRUCTURES AND RELATED METHODS Jun 8, 2022 Pending
Array ( [id] => 19777384 [patent_doc_number] => 12226404 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-02-18 [patent_title] => Methods for making compositions for pulmonary administration [patent_app_type] => utility [patent_app_number] => 17/836067 [patent_app_country] => US [patent_app_date] => 2022-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 15 [patent_no_of_words] => 13430 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17836067 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/836067
Methods for making compositions for pulmonary administration Jun 8, 2022 Issued
Array ( [id] => 18716491 [patent_doc_number] => 11793813 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-24 [patent_title] => Pemetrexed formulations [patent_app_type] => utility [patent_app_number] => 17/835236 [patent_app_country] => US [patent_app_date] => 2022-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 9355 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17835236 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/835236
Pemetrexed formulations Jun 7, 2022 Issued
Array ( [id] => 18270810 [patent_doc_number] => 20230092052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-23 [patent_title] => INTERPENETRATING NETWORK HYDROGELS WITH INDEPENDENTLY TUNABLE STIFFNESS [patent_app_type] => utility [patent_app_number] => 17/748330 [patent_app_country] => US [patent_app_date] => 2022-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17782 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17748330 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/748330
INTERPENETRATING NETWORK HYDROGELS WITH INDEPENDENTLY TUNABLE STIFFNESS May 18, 2022 Abandoned
Array ( [id] => 18195353 [patent_doc_number] => 20230048872 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-16 [patent_title] => COMPOSITIONS AND METHODS FOR DIAGNOSING OR TREATING NEUTROPHIL-MEDIATED INFLAMMATORY DISEASE [patent_app_type] => utility [patent_app_number] => 17/745567 [patent_app_country] => US [patent_app_date] => 2022-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4668 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17745567 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/745567
COMPOSITIONS AND METHODS FOR DIAGNOSING OR TREATING NEUTROPHIL-MEDIATED INFLAMMATORY DISEASE May 15, 2022 Abandoned
Array ( [id] => 18003351 [patent_doc_number] => 20220362117 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-17 [patent_title] => Effective treatment for dandruff, a composition for treating dandruff and a method for making same [patent_app_type] => utility [patent_app_number] => 17/744701 [patent_app_country] => US [patent_app_date] => 2022-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4923 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17744701 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/744701
Effective treatment for dandruff, a composition for treating dandruff and a method for making same May 14, 2022 Abandoned
Array ( [id] => 19273314 [patent_doc_number] => 12023421 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-07-02 [patent_title] => Medical devices for continuous delivery of therapeutic agents [patent_app_type] => utility [patent_app_number] => 17/734889 [patent_app_country] => US [patent_app_date] => 2022-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 59 [patent_no_of_words] => 18179 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17734889 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/734889
Medical devices for continuous delivery of therapeutic agents May 1, 2022 Issued
Array ( [id] => 17774965 [patent_doc_number] => 20220241314 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-04 [patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT OF HEPATITIS B VIRUS INFECTION [patent_app_type] => utility [patent_app_number] => 17/710783 [patent_app_country] => US [patent_app_date] => 2022-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18665 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -50 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17710783 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/710783
COMPOSITIONS AND METHODS FOR TREATMENT OF HEPATITIS B VIRUS INFECTION Mar 30, 2022 Pending
Array ( [id] => 17759928 [patent_doc_number] => 20220233540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-28 [patent_title] => COMPOSITIONS AND METHODS FOR INHIBITING TCF/LEF TRANSCRIPTIONAL ACTIVITY [patent_app_type] => utility [patent_app_number] => 17/680295 [patent_app_country] => US [patent_app_date] => 2022-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14097 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17680295 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/680295
COMPOSITIONS AND METHODS FOR INHIBITING TCF/LEF TRANSCRIPTIONAL ACTIVITY Feb 24, 2022 Pending
Array ( [id] => 17865375 [patent_doc_number] => 20220288110 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-15 [patent_title] => DRUG TREATMENT AND BIOMARKER PANEL TARGETED TO DISEASES DUE TO MULTIFACTORIAL ONTOLOGY OF GLYCOCALYX DISRUPTION [patent_app_type] => utility [patent_app_number] => 17/675674 [patent_app_country] => US [patent_app_date] => 2022-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26849 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17675674 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/675674
DRUG TREATMENT AND BIOMARKER PANEL TARGETED TO DISEASES DUE TO MULTIFACTORIAL ONTOLOGY OF GLYCOCALYX DISRUPTION Feb 17, 2022 Abandoned
Array ( [id] => 17657420 [patent_doc_number] => 20220177885 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-09 [patent_title] => ENDOSOMAL CLEAVABLE LINKERS [patent_app_type] => utility [patent_app_number] => 17/668917 [patent_app_country] => US [patent_app_date] => 2022-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58222 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17668917 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/668917
ENDOSOMAL CLEAVABLE LINKERS Feb 9, 2022 Pending
Array ( [id] => 17776857 [patent_doc_number] => 20220243206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-04 [patent_title] => LIPOPOLYSACCHARIDE (LPS) APTAMERS AND ASSOCIATED METHODS [patent_app_type] => utility [patent_app_number] => 17/591485 [patent_app_country] => US [patent_app_date] => 2022-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3044 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17591485 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/591485
LIPOPOLYSACCHARIDE (LPS) APTAMERS AND ASSOCIATED METHODS Feb 1, 2022 Pending
Array ( [id] => 18225885 [patent_doc_number] => 20230064879 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-02 [patent_title] => NANODRUG PARTICLES, THE USE THEREOF, AND PREPARATION METHOD THEREOF [patent_app_type] => utility [patent_app_number] => 17/589223 [patent_app_country] => US [patent_app_date] => 2022-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4061 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17589223 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/589223
NANODRUG PARTICLES, THE USE THEREOF, AND PREPARATION METHOD THEREOF Jan 30, 2022 Abandoned
Array ( [id] => 17790448 [patent_doc_number] => 20220249539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-11 [patent_title] => BOLAAMPHIPHILIC COMPOUNDS, COMPOSITIONS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/587743 [patent_app_country] => US [patent_app_date] => 2022-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27522 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17587743 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/587743
BOLAAMPHIPHILIC COMPOUNDS, COMPOSITIONS AND USES THEREOF Jan 27, 2022 Pending
Array ( [id] => 17748017 [patent_doc_number] => 20220226220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-21 [patent_title] => COMPOSITION FOR PREVENTING GRAY HAIR, PROMOTING BLACK HAIR AND PREVENTING, IMPROVING OR TREATING VITILIGO OR HYPOCHROMATISM COMPRISING FRUCTOSE 1,6-BISPHOSPHATE OR SALT, SOLVATE, STEREOISOMER OR HYDRATE THEREOF AS ACTIVE INGREDIENT [patent_app_type] => utility [patent_app_number] => 17/578949 [patent_app_country] => US [patent_app_date] => 2022-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5642 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17578949 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/578949
Composition for preventing gray hair, promoting black hair and preventing, improving or treating vitiligo or hypochromatism comprising fructose 1,6-bisphosphate or salt, solvate, stereoisomer or hydrate thereof as active ingredient Jan 18, 2022 Issued
Array ( [id] => 17561551 [patent_doc_number] => 20220125700 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-28 [patent_title] => BIO-DEGRADABLE MICROCAPSULES [patent_app_type] => utility [patent_app_number] => 17/570498 [patent_app_country] => US [patent_app_date] => 2022-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3851 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17570498 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/570498
BIO-DEGRADABLE MICROCAPSULES Jan 6, 2022 Pending
Array ( [id] => 18871099 [patent_doc_number] => 11858884 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-02 [patent_title] => Compositions and methods for modulating gene or gene product in cells [patent_app_type] => utility [patent_app_number] => 17/566666 [patent_app_country] => US [patent_app_date] => 2021-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 48 [patent_no_of_words] => 32623 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17566666 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/566666
Compositions and methods for modulating gene or gene product in cells Dec 29, 2021 Issued
Menu